# Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS）

> **NCT05087706** · — · UNKNOWN · sponsor: **Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University** · enrollment: 182 (estimated)

## Conditions studied

- Salivary Gland Neoplasms

## Interventions

- **DRUG:** Pyrotinib
- **DRUG:** Bicalutamide
- **DRUG:** Leuprorelin

## Key facts

- **NCT ID:** NCT05087706
- **Lead sponsor:** Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-30
- **Primary completion:** 2023-03-19
- **Final completion:** 2023-09-19
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05087706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05087706, "Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS）". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05087706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*